Return to homepagePandemic Pact

The COVID-19 Genomics UK (COG-UK) Consortium

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-200

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    N/A

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Cancer Unit

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Together with the Wellcome Sanger Institute, the University of Cambridge is leading the national COVID-19 Genomics UK (COG-UK) consortium, created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres and the UK government. Funded by a £20 million investment from UK Department of Health and Social Care (DHSC), UK Research and Innovation (UKRI) and the Wellcome Trust, COG-UK is an innovative partnership between NHS organisations, the four Public Health Agencies of the UK, and over twelve academic partners providing sequencing and analysis capacity.